IP Library Granted Patent US 9,834,780
Granted Patent B2
US 9,834,780 · App. 14/685,361 · Granted Dec 5, 2017

Reducing levels of nicotinic alkaloids in plants

Inventors: Takashi Hashimoto (Ikoma, JP); Akira Kato (Nara, JP)
Assignee: 22nd Century Limited, LLC
C12N15/8243A01H5/12A23K20/10A23L33/105A24B13/00A24B13/02A24B15/10A24B15/18A24B15/20A24B15/243A24D1/00A24F47/00C07K14/415C12N15/113C12N15/8213C12N15/8218C12Q1/6895A23V2002/00C12Q2600/158Y02E50/17
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,834,780
App. No.
14/685,361
Granted
Dec 5, 2017
Kind
B2
Abstract

Two genes, A622 and NBB1, can be influenced to achieve a decrease of nicotinic alkaloid levels in plants. In particular, suppression of one or both of A622 and NBB1 may be used to decrease nicotine in tobacco plants.

Claims (8)

1. A method for producing a tobacco plant cell having suppression of a gene product encoded by SEQ ID NO: 3, comprising genetically engineering a population of plant cells to suppress production of the gene product encoded by SEQ ID NO: 3, comprising introducing one or more mutations into the region of SEQ ID NO: 3

that encodes a polypeptide having the amino acid sequence set forth in SEQ ID NO: 4, wherein the plant cells exhibit reduced expression of the gene product as compared to a non-transformed control cell.

2. A plant cell produced by the method of claim 1 , wherein the plant cell comprises in its genome the one or more mutations and exhibits reduced expression of the gene product encoded by SEQ ID NO: 3 as compared to a non-transformed control cell.

3. A plant having suppression of the gene product encoded by SEQ ID NO: 3 and a reduced nicotine level, as compared to a control plant, produced from the plant cell of claim 2 .

4. A product comprising the plant of claim 3 , and having a reduced level of nicotine as compared to a product produced from a control plant, wherein the product is selected from the group consisting of a tobacco product, food product, food ingredient, feed product, feed ingredient, nutritional supplement, and biofuel.

5. The tobacco product of claim 4 , wherein the product is selected from the group consisting of smoking cessation products, cigarettes, cigarette tobacco, cigars, cigar tobacco, snus, pipe tobacco, and chewing tobacco.

6. The method of claim 1 , wherein the genetic engineering comprises introducing into the population of cells a reagent comprising a recombinagenic oligonucleobase to introduce said mutations.

7. Seeds from the plant of claim 3 or progeny plant thereof, wherein the seeds comprise in their genomes the one or more mutations.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded Mar 29, 2023
From: 22ND CENTURY GROUP, INC.
To: JGB COLLATERAL, LLC
Reel/Frame 063188/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2021
From: NARA INSTITUTE OF SCIENCE AND TECHNOLOGY
To: 22ND CENTURY LIMITED, LLC
Reel/Frame 055657/0991 →
Continuity (4)
Division 13082953 · Apr 8, 2011
Continuation 11579661
Provisional Application 60656536 · Feb 28, 2005
Related Publication 20150284734A1 · Oct 8, 2015